Stocklytics Platform
Asset logo for symbol NEXI
NexImmune
NEXI57
$0.20arrow_drop_down0.49%-$0.00
Penny Stock
Asset logo for symbol NEXI
NEXI57

$0.20

arrow_drop_down0.49%
query_stats

NEXI is not a dividend stock

Therefore Dividends subscore should not be taken into consideration

For certain stocks classified as non-dividend stocks, dividend-related data may not be available or applicable. Non-dividend stocks are those where the company does not regularly distribute dividends to its shareholders.

Why No Data?

Non-dividend stocks typically do not offer regular dividend payments. As a result, there might be no dividend-related information or history for such stocks within our database.

Understanding Non-Dividend Stocks

Non-dividend stocks are characterized by companies that reinvest their profits back into the business for expansion, research, development, or other strategic purposes rather than distributing dividends to shareholders.

What This Means for Investors

Investors in non-dividend stocks often focus on capital appreciation, anticipating the value of their shares to increase over time without relying on dividend income.

Stay Updated

While dividend information may not be available for these stocks, other critical financial metrics and analyses are accessible on Stocklytics to aid in informed investment decisions.

Stock Split History (NEXI)

DateSplitMultipleCumulative
Multiple
Oct 19, 20231:25x0x0

NexImmune (NEXI) Dividends & Splits

NexImmune, Inc. (NEXI) does not currently offer dividends or splits. As a biotechnology company focused on developing novel cell-based immunotherapies for cancer, NexImmune prioritizes reinvesting its resources into research and development. The company aims to advance its pipeline of innovative therapies and bring them to market to benefit patients in need. Therefore, dividends are not part of NexImmune's current strategy.
Investors should note that the absence of dividends and splits does not necessarily indicate a negative outlook for NexImmune. Many biotechnology companies reinvest their earnings to fuel further growth and development, as they prioritize advancing their therapeutic candidates. NexImmune is committed to maximizing the potential of its proprietary AIM technology platform and advancing its pipeline through rigorous clinical trials and regulatory approvals.
add NexImmune to watchlist

Keep an eye on NexImmune

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

Does NexImmune (NEXI) stock pay dividends?

No, NexImmune (NEXI) does not pay dividends. This could indicate that the company is currently focusing on reinvesting its earnings into growth opportunities rather than distributing them as dividends.
help

When was the last NexImmune (NEXI) stock split?

NexImmune (NEXI) has undergone 1 total stock splits. The most recent split was a 1:25 split on 2023 Oct 19, leaving the company with 1.39M shares outstanding. Since the company's inception, the cumulative multiple from splits is 0, indicating the overall effect of all splits on the original share count.

Take Your Investments to a Whole New Level